GCG and alkaline phosphatase measurement: Up to 80 per cent of patients with type 3c DM suffer both exocrine and endocrine insufficiency, and the loss of pancreatic tissue is linked to changes in inflammatory and counter-regulatory hormones after AP, including an altered glucagon secretion and changes in pancreatic polypeptide and hepatic glucose sensitivity10,29–32.